🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

36 results for “Legend” Clear

  1. LCAR-B38M CAR-T Cell

    Legend Biotech Corp

    Multiple Myeloma

    phase 2 mab terminated

    1 trial

  2. LCAR-B38M CAR-T cell injection

    Legend Biotech Corp

    Refractory or Relapsed Multiple Myeloma

    phase 2 mab active

    1 trial

  3. CAR-T Re-treatment

    Legend Biotech Corp

    Multiple Myeloma

    phase 1 small molecule active

    1 trial

  4. CD19/CD20 Dual-Target in vivo CAR-T Lentiviral product

    Legend Biotech Corp

    Relapsed/Refractory B-cell Malignancies

    phase 1 mab active

    1 trial

  5. Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy

    Legend Biotech Corp

    Lymphoma, B-Cell

    phase 1 small molecule terminated

    1 trial

  6. Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy

    Legend Biotech Corp

    Refractory B Acute Lymphoblastic Leukemia

    phase 1 small molecule terminated

    1 trial

  7. Efficacy of LCAR-T2C CAR-T cells

    Legend Biotech Corp

    T Cell Lymphoma

    phase 1 small molecule terminated

    1 trial

  8. Efficacy of LCAR-T2C CAR-T cells

    Legend Biotech Corp

    CD4+ T Lymphocyte Tumor (T Cell Lymphoma and T Cell Leukemia)

    phase 1 small molecule terminated

    1 trial

  9. LB1901

    Legend Biotech Corp

    T-Cell Lymphoma

    phase 1 mab active

    1 trial

  10. LB1908

    Legend Biotech Corp

    Gastric Cancer

    phase 1 mab active

    1 trial

  11. LB2102

    Legend Biotech Corp

    Small Cell Lung Cancer Extensive Stage

    phase 1 mab active

    1 trial

  12. LCAR-AIO T cells

    Legend Biotech Corp

    Systemic Lupus Erythematosus (SLE)

    phase 1 mab active

    1 trial

  13. LCAR-AIO T cells

    Legend Biotech Corp

    Multiple Sclerosis (MS)

    phase 1 mab active

    1 trial

  14. LCAR-AIO T cells

    Legend Biotech Corp

    Relapsed/Refractory Autoimmune Diseases

    phase 1 mab terminated

    1 trial

  15. LCAR-AIO cells product

    Legend Biotech Corp

    B-cell Lymphoma Recurrent

    phase 1 mab terminated

    1 trial

  16. LCAR-AMDR Cells Product

    Legend Biotech Corp

    Acute Myeloid Leukemia

    phase 1 mab terminated

    1 trial

  17. LCAR-B4822M CAR-T Cell Immunotherapy

    Legend Biotech Corp

    Refractory or Relapsed Multiple Myeloma

    phase 1 small molecule active

    1 trial

  18. LCAR-BCDR cells product

    Legend Biotech Corp

    Relapsed/Refractory Multiple Myeloma

    phase 1 mab terminated

    1 trial

  19. LCAR-BCX cells product

    Legend Biotech Corp

    Relapsed/Refractory Multiple Myeloma

    phase 1 mab active

    1 trial

  20. LCAR-C182A cells

    Legend Biotech Corp

    Gastric Cancer

    phase 1 mab terminated

    1 trial

  21. LCAR-C18S cells

    Legend Biotech Corp

    Solid Tumors, Adult

    phase 1 mab terminated

    1 trial

  22. LCAR-G08 cells

    Legend Biotech Corp

    Advanced Gastrointestinal Tumors

    phase 1 mab terminated

    1 trial

  23. LCAR-HL30 cells

    Legend Biotech Corp

    Hodgkin's Lymphoma

    phase 1 mab active

    1 trial

  24. LCAR-M23 cells

    Legend Biotech Corp

    Epithelial Ovarian Cancer

    phase 1 mab terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources